Telix Pharmaceuticals (TLX) Inventory (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Inventory data on file, last reported at $37.1 million in Q4 2025.

• Inventory for Q4 2025 came in at $37.1 million, up 48.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $37.1 million (up 48.65% YoY), and the FY2025 annual result was $37.1 million, up 56.99% from the prior year.
• Inventory improved to $37.1 million in Q4 2025 per TLX's latest filing, from $24.9 million in the prior quarter.
• Over five years, Inventory peaked at $37.1 million in Q4 2025 and troughed at $11.3 million in Q4 2023.
• A 3-year average of $24.4 million and a median of $24.9 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2025: Inventory jumped 121.36% in 2024, then jumped 48.65% in 2025.
• A 3-year view of Inventory shows it stood at $11.3 million in 2023, then jumped by 121.36% to $24.9 million in 2024, then surged by 48.65% to $37.1 million in 2025.
• Business Quant data shows TLX's Inventory at $37.1 million in Q4 2025, $24.9 million in Q4 2024, and $11.3 million in Q4 2023.